Literature DB >> 10492271

Chylothorax in children: guidelines for diagnosis and management.

V Büttiker1, S Fanconi, R Burger.   

Abstract

STUDY
OBJECTIVE: To establish guidelines for the diagnosis and management of chylothorax in children.
DESIGN: Retrospective study. PATIENTS: Fifty-one patients with a diagnosis of chylothorax. Twelve patients were excluded because of incomplete data or incorrect diagnosis. The following parameters were analyzed: triglyceride level, total cell number, and lymphocyte percentage; amount of pleural effusion on day of diagnosis, day 5, and day 14; and total time of pleural effusion. Prospectively, the same parameters were analyzed in a control group of 10 patients with pleural drainage. INTERVENTION: Patients with chylothorax were treated primarily with fat-free oral nutrition; if chyle did not stop, total parenteral nutrition with total enteric rest was started. If conservative therapy was not successful, pleurodesis was performed.
RESULTS: In children with chylothorax triglyceride, triglyceride content ranged from 0.56 to 26.6 mmol/L; all values except one were > 1.1 mmol/L. In 36 of 39 patients (92%), the cell count was > 1,000 cells/microL. In 33 of 39 patients (85%), lymphocytes were > 90%. In patients without chylothorax triglyceride, triglyceride levels ranged from 0.1 to 0.71 mmol/L (median, 0.38 mmol/L) and cell count was from 20 to 1400 cells/microL (median, 322 cells/microL), with a maximum of 60% lymphocytes. With fat-free nutrition, chyle disappeared in 29 of 39 patients. Five patients died, and five required pleurodesis.
CONCLUSIONS: Pleural effusion in children is chyle when it contains > 1.1 mmol/L triglycerides (with oral fat intake) and has a total cell count > or 1,000 cells/microL, with a lymphocyte fraction > 80%. Chylous effusions usually last long; however, after 6 weeks, the majority of the effusions (29 of 39 patients) had ceased. Late surgical interventions reduce the number of thoracotomies substantially, but can lead to very long hospitalization times. Early surgical interventions (after < 3 weeks) lead to a high number of thoracotomies, but certainly reduce hospitalization time.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492271     DOI: 10.1378/chest.116.3.682

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  30 in total

1.  Successful treatment of congenital chylothorax using fibrin glue.

Authors:  N B Mathur; Bijender Singh; Ajay Kumar; S K Aggarwal
Journal:  Indian J Pediatr       Date:  2009-07       Impact factor: 1.967

2.  Conservative management of chylothorax after coronary artery bypass grafting.

Authors:  Gokalp Altun; Zerrin Pulathan; Dilek Kutanis; Dogus Hemsinli; Engin Erturk; Ali Civelek
Journal:  Tex Heart Inst J       Date:  2015-04-01

3.  Continuous infusion of nafcillin for sternal osteomyelitis in an infant after cardiac surgery.

Authors:  Chad A Knoderer; Jennifer L Morris; Elaine G Cox
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

4.  Oesophageal inflammatory paediatric chylothorax.

Authors:  Thomas Aherne; Paul Cullen; Alan Mortell; Jonathan McGuinness
Journal:  BMJ Case Rep       Date:  2014-06-11

5.  Chylothorax in congenital diaphragmatic hernia.

Authors:  Alejandro Zavala; José-Manuel Campos; Cecilia Riutort; Ilona Skorin; Loreto Godoy; Miriam Faunes; Javier Kattan
Journal:  Pediatr Surg Int       Date:  2010-08-01       Impact factor: 1.827

Review 6.  Surgical chylothorax in neonates: management and outcomes.

Authors:  Karina Miura Costa; Amulya Kumar Saxena
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

7.  Predictors of prolonged drainage of chylothorax after cardiac surgery: single centre study.

Authors:  Sameh Ibrahim Sersar
Journal:  Pediatr Surg Int       Date:  2011-06-10       Impact factor: 1.827

8.  Chylopericardial tamponade secondary to superior vena cava thrombosis in a child with nephrotic syndrome.

Authors:  Deepti Suri; Neeraj Gupta; Chandrashekara Morigeri; Akshay Saxena; Rohit Manoj
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

Review 9.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

10.  The role of pleurodesis in the management of chylous pleural effusion after surgery for congenital heart disease.

Authors:  Poomiporn Katanyuwong; Joseph Dearani; David Driscoll
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.